Trust Company of Vermont’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-285
| Closed | -$19K | – | 989 |
|
|
2019
Q3 | $19K | Hold |
285
| – | – | ﹤0.01% | 632 |
|
|
2019
Q2 | $17K | Hold |
285
| – | – | ﹤0.01% | 665 |
|
|
2019
Q1 | $20K | Hold |
285
| – | – | ﹤0.01% | 612 |
|
|
2018
Q4 | $18K | Hold |
285
| – | – | ﹤0.01% | 643 |
|
|
2018
Q3 | $20K | Hold |
285
| – | – | ﹤0.01% | 690 |
|
|
2018
Q2 | $14K | Hold |
285
| – | – | ﹤0.01% | 765 |
|
|
2018
Q1 | $9K | Hold |
285
| – | – | ﹤0.01% | 773 |
|
|
2017
Q4 | $10K | Hold |
285
| – | – | ﹤0.01% | 766 |
|
|
2017
Q3 | $9K | Hold |
285
| – | – | ﹤0.01% | 753 |
|
|
2017
Q2 | $9K | Hold |
285
| – | – | ﹤0.01% | 755 |
|
|
2017
Q1 | $9K | Hold |
285
| – | – | ﹤0.01% | 737 |
|
|
2016
Q4 | $8K | Hold |
285
| – | – | ﹤0.01% | 733 |
|
|
2016
Q3 | $8K | Hold |
285
| – | – | ﹤0.01% | 700 |
|
|
2016
Q2 | $7K | Hold |
285
| – | – | ﹤0.01% | 661 |
|
|
2016
Q1 | $7K | Hold |
285
| – | – | ﹤0.01% | 632 |
|
|
2015
Q4 | $10K | Hold |
285
| – | – | ﹤0.01% | 630 |
|
|
2015
Q3 | $6K | Hold |
285
| – | – | ﹤0.01% | 687 |
|
|
2015
Q2 | $8K | Hold |
285
| – | – | ﹤0.01% | 687 |
|
|
2015
Q1 | $9K | Hold |
285
| – | – | ﹤0.01% | 656 |
|
|
2014
Q4 | $9K | Hold |
285
| – | – | ﹤0.01% | 659 |
|
|
2014
Q3 | $8K | Hold |
285
| – | – | ﹤0.01% | 678 |
|
|
2014
Q2 | $8K | Hold |
285
| – | – | ﹤0.01% | 655 |
|
|
2014
Q1 | $8K | Hold |
285
| – | – | ﹤0.01% | 647 |
|
|
2013
Q4 | $8K | Hold |
285
| – | – | ﹤0.01% | 622 |
|
|
2013
Q3 | $9K | Hold |
285
| – | – | ﹤0.01% | 595 |
|
|
2013
Q2 | $9K | Buy |
+285
| New | +$9K | ﹤0.01% | 591 |
|